THEOBALD HEPATITIS B FOUNDATION
HEPATITIS B IS TREATABLE
GET TESTED

Contact Us

Contact us for support.

Click Here

Hepatitis B

Hepatitis B is treatable and preventable. How?

Click Here

FAQs

Answers to some tough questions about hepatitis B.

Click Here

A New Approach to Hepatitis B Therapy?

Cyclophilins are involved in multiple steps of the hepatitis B virus (HBV) life cycle in hepatocytes—cyclophilin inhibitors reduce viral replication and HBV envelope protein production and secretion, researchers report in the February issue of Gastroenterology. The cyclophilin inhibitor alisporivir, combined with the HBV polymerase inhibitor, reduces markers of HBV infection and HBV replication in cells, […]

Age and HBsAg level predict NA-induced HBeAg seroconversion durability

The combination of age and baseline hepatitis B s-antigen (HBsAg) level can help predict hepatitis B virus (HBV) relapse in patients who achieve hepatitis B e-antigen (HBeAg) loss or seroconversion following nucleos(t)ide analogue (NA) treatment, researchers report. They found that being 40 years of age or older and having baseline HBsAg levels of 2000 IU/mL […]

Discrimination ‘still rampant’ vs Filipinos with Hepatitis B

Aside from dealing with the disease itself, Filipinos with Hepatitis B also suffer from discrimination at the workplace or at home. MANILA, Philippines – Despite efforts to increase public awareness on Hepatitis B, advocates fighting to eradicate the disease say discrimination against patients is “still rampant.” Dr Eternity Labio, Hepatology Society of the Philippines (HSP) […]

Long-Term Effects of Antivirals in Patients with HBV-Related Cirrhosis

Oral antivirals are considered to be safe and effective in hepatitis B virus (HBV) suppression and improvement in liver disease in patients with HBV-related decompensation; however, it is not known if this leads to avoidance or reduction in liver transplantation (LT) or what the long-term outcomes are in patients with decompensated cirrhosis. A new prospective, […]

Anti-viral regimens did not increase risk for renal effects in HBV

Anti-viral therapy did not increase any risk for renal disease among patients with hepatitis B virus infection, with or without renal risk factors before treatment, according to study data. “Renal impairment during the course of anti-viral treatment of hepatitis B still needs to be clarified whether it is related to anti-viral nephrotoxicity or pre-existing risk […]

Falling Through the Cracks: Mothers With Hepatitis B Receive Inadequate Treatment, Follow-up

More than one-third of women with the hepatitis B virus (HBV) are initially diagnosed with the infection at their first prenatal care visit, but they do not receive follow-up care for the infection after their pregnancy, researchers have found. The retrospective study examined the medical records of 243 women with HBV who received prenatal care […]

Scientists Claim Coffee Protects Our Liver

As it turned out, coffee protects our liver. It was found that coffee not only gives us anenergy boost, but also protects the liver. The results of the recent study suggest that two cups of a coffee per day can lower risks of death from liver cirrhosis by 60%. The research is published in the […]

Victorian hepatitis B sufferers to test ‘cure’ in Victorian trial

A TREATMENT that could cure a viral disease carried by two billion people worldwide will be trialled in Victorian hepatitis B patients for the first time. Although a vaccine has been available for more than three decades, if successful, this treatment would help up to 400 million people living with chronic infections and stop mothers […]

AASLD 2014: Tenofovir Continues to Work Well Against Hepatitis B Virus for 8 Years

Most chronic hepatitis B patients treated with tenofovir (Viread) for 8 years continued to maintain viral suppression, researchers reported at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last week in Boston.Serological response rates continued to increase over time and kidney and bone-related side effects remained uncommon. Nucleoside/nucleotide analog antivirals such […]

Health Chat show on Voice of America

The President of the Theobald Hepatitis B Foundation and Hepatitis Coalition of Ghana, Mr.Owusu-Ansah will be a guest on Voice of America health chat show this Tuesday November 11th from 12:30pm to 1pm in Washington which will be 5:3opm to 6pm in Ghana. Health chat is VOA’s weekly live call in radio program that covers […]